Effects of lovastatin on ApoA- and ApoB-containing lipoproteins. Families in a subpopulation of patients participating in the Monitored Atherosclerosis Regression Study (MARS).

scientific article published on December 1994

Effects of lovastatin on ApoA- and ApoB-containing lipoproteins. Families in a subpopulation of patients participating in the Monitored Atherosclerosis Regression Study (MARS). is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1161/01.ATV.14.12.1906
P698PubMed publication ID7981178

P2093author name stringP Alaupovic
H N Hodis
W J Mack
D H Blankenhorn
D M Kramsch
L Cashin-Hemphill
L LaBree
C N Corder
C Knight-Gibson
P433issue12
P407language of work or nameEnglishQ1860
P304page(s)1906-1913
P577publication date1994-12-01
P1433published inArteriosclerosis and thrombosis : a journal of vascular biologyQ27709770
P1476titleEffects of lovastatin on ApoA- and ApoB-containing lipoproteins. Families in a subpopulation of patients participating in the Monitored Atherosclerosis Regression Study (MARS)
P478volume14

Reverse relations

cites work (P2860)
Q34552595An update on carotid ultrasound measurement of intima-media thickness
Q88167231Apolipoprotein-defined lipoprotein subclasses, serum apolipoproteins, and carotid intima-media thickness in T1D
Q33781706Apolipoprotein-defined lipoproteins and apolipoproteins: associations with abnormal albuminuria in type 1 diabetes in the diabetes control and complications trial/epidemiology of diabetes interventions and complications cohort
Q47764147Biologic markers as predictors of cardiovascular disease
Q54171141Changes in plasma lipid and apolipoprotein levels between heparin-induced extracorporeal low-density lipoprotein precipitation (HELP) treatments.
Q34552563Documenting regression of atherosclerosis: practical approaches in drug development
Q73589935Effect of a new HMG-CoA reductase inhibitor, atorvastatin, on lipids, apolipoproteins and lipoprotein particles in patients with elevated serum cholesterol and triglyceride levels
Q40338516Effect of fluvastatin on apolipoprotein-defined lipoprotein subclasses in patients with chronic renal insufficiency
Q38293501Effects of established hypolipidemic drugs on HDL concentration, subclass distribution, and function
Q51565712Effects of fibric acid derivatives and metformin on postprandial lipemia.
Q37457665Factor II activity is similarly increased in patients with elevated apolipoprotein CIII and in carriers of the factor II 20210A allele
Q73110411The effect of aggressive and moderate lowering of LDL-cholesterol and low dose anticoagulation on plasma lipids, apolipoproteins and lipoprotein families in post coronary artery bypass graft trial
Q48033046Use of apolipoprotein parameters and endpoints in drug development and approval processes

Search more.